Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01924572 · ClinicalTrials.gov registry record · NA

Placental Transfusion in Term Infants: A Pilot Study

A NA study of Anemia, sponsored by University of Rhode Island.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT01924572 is a NA study of Anemia that has completed, run by University of Rhode Island. The registered enrollment target is 32 participants, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01924572, a NA study of Anemia, has completed, sponsored by University of Rhode Island.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The proposed study is a pilot prospective controlled trial to measure the blood volume left in the placenta after varying cord clamping times when the infant is placed skin-to-skin on the maternal abdomen. Delaying cord clamping has been shown to decrease anemia in infants. However, the best way to get the most blood to the baby is not known. The practice of cord clamping at birth is not the same among doctors and midwives and we do not know the effect of putting he baby on the mother's abdomen.

Conditions Studied

Interventions

  • PROCEDURE cord clamping at 2 minutes
  • PROCEDURE cord clamping at 5 minutes
  • PROCEDURE cord milking

Study Locations (1)

Rhode Island

  • Women & Infants Hospital - Providence

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2010-07
Est. Completion 2011-05
Phase NA

Sponsor

University of Rhode Island

29 total trials

What the Registry Record Tells You About NCT01924572

The ClinicalTrials.gov registry entry for NCT01924572 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (93% lower). The listed sponsor is University of Rhode Island, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anemia appearing as the primary indexed condition, and to 3 interventions - of which cord clamping at 2 minutes is the first listed.

NCT01924572 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT01924572 about?

NCT01924572 is a clinical study titled "Placental Transfusion in Term Infants: A Pilot Study". The proposed study is a pilot prospective controlled trial to measure the blood volume left in the placenta after varying cord clamping times when the infant is placed skin-to-skin on the maternal abdomen. Delaying cord clamping has been shown to decrease anemia in infants. However, the best way to ...

What is the current status of trial NCT01924572?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2010-07. Estimated completion is 2011-05.

What conditions does trial NCT01924572 study?

This clinical trial studies the following conditions: Anemia.

What interventions are being tested in trial NCT01924572?

The interventions under investigation include: cord clamping at 2 minutes (PROCEDURE), cord clamping at 5 minutes (PROCEDURE), cord milking (PROCEDURE).

Who is sponsoring clinical trial NCT01924572?

This trial is sponsored by University of Rhode Island, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01924572 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.